Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Imagion Biosystems Ltd. ( (AU:IBX) ) is now available.
Imagion Biosystems has scheduled its 2026 Annual General Meeting for 26 May 2026 in Melbourne and has set 5pm AEST on 14 April 2026 as the deadline for shareholders to submit nominations for candidates to stand for election as directors. The forthcoming AGM and associated board nomination process underscore routine governance milestones for the clinical-stage imaging company, with further details to be provided to shareholders via the formal notice of meeting and proxy materials in line with statutory requirements.
The most recent analyst rating on (AU:IBX) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Imagion Biosystems Ltd. stock, see the AU:IBX Stock Forecast page.
More about Imagion Biosystems Ltd.
Imagion Biosystems Limited is a clinical-stage medical imaging company focused on transforming cancer diagnosis and treatment. Its proprietary MagSense® molecular MRI imaging agents use non-radioactive, bio-safe magnetic nanoparticles to enable earlier and more precise detection of cancers, including HER2-positive breast, prostate, and ovarian cancers.
Average Trading Volume: 2,155,192
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.79M
Find detailed analytics on IBX stock on TipRanks’ Stock Analysis page.